Kirkland & Ellis advised Energy Transfer LP and Vinson & Elkins advised Crestwood Equity Partners LP on the transaction. Bracewell represented Evercore as financial advisor to...
Energy Transfer’s $7.1 Billion Acquisition of Crestwood
Gracell Biotechnologies’ $150 Million Private Placement Financing
Cooley advised Gracell Biotechnologies; and Davis Polk & Wardwell advised the placement agents on the deal. Gracell Biotechnologies Inc. (Nasdaq: GRCL) announced that it has entered into a...
General Electric’s $1.95 Billion Debt-for-Equity Exchange
Gibson Dunn advised GE HealthCare Technologies, Paul, Weiss advised General Electric, and Simpson Thacher advised the representatives of the underwriters. Simpson Thacher also represented Morgan Stanley...
Editas Medicine’s $125 Million Shares Offering
Davis Polk advised the joint book-running managers in the offering. Editas Medicine, Inc. (Nasdaq: EDIT) announced the pricing of an underwritten offering of 12,500,000 shares of its...
Mobileye’s $1.617 Billion Secondary Offering
Davis Polk & Wardwell LLP advised Mobileye Global Inc on the offering, while Sullivan & Cromwell LLP advised the underwriters. Mobileye Global Inc., a leader of the...
Gates Industrial’s $304 Million Secondary Offering
Simpson Thacher represented Gates Industrial Corporation plc on the offering, while Davis Polk advised Citigroup Global Markets Inc., Evercore Group L.L.C. and Goldman Sachs & Co....
EVgo’s $125 Million Public Equity Offering
Freshfields Bruckhaus advised EVgo, and Latham & Watkins advised the underwriters. EVgo Inc. announced the pricing on May 17, 2023 of an underwritten public offering of 29,411,765...
Emergent BioSolutions’ $150 Million At-the-market Offering
Davis Polk advised the sales agents, RBC Capital Markets, LLC and Evercore Group L.L.C., on the transaction. Emergent BioSolutions Inc., an American multinational specialty biopharmaceutical company headquartered in...
Vaxcyte’s $500 Million Public Offering
Cooley advises Vaxcyte on the offering, and Latham & Watkins advises the underwriters. Vaxcyte, Inc. (Nasdaq: PCVX) has announced the pricing of an underwritten public offering...
BridgeBio Pharma’s $150 Million Common Stock Public Offering
Goodwin Procter advised BridgeBio Pharma on the offering, and Latham & Watkins advised the underwriters involved. BridgeBio Pharma, Inc. announced the pricing on March 7, 2023 of...
Longboard Pharmaceuticals’ $20 Million Common Stock Offering
Cooley advised Longboard Pharmaceuticals on the offering, and Latham & Watkins advised the underwriters involved. Longboard Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public...
Sisecam Chemicals Wyoming LLC’s Acquisition of Sisecam Resources LP
The Conflicts Committee engaged Potter Anderson & Corroon LLP as its legal advisor and Evercore as its financial advisor. Gibson, Dunn & Crutcher LLP assisted Evercore....